Citizens Financial Group Inc. RI Invests $379,000 in Molina Healthcare, Inc $MOH

Citizens Financial Group Inc. RI acquired a new position in shares of Molina Healthcare, Inc (NYSE:MOH) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 2,840 shares of the company’s stock, valued at approximately $379,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of MOH. Baird Financial Group Inc. acquired a new position in shares of Molina Healthcare during the first quarter worth $210,000. NewEdge Advisors LLC boosted its position in shares of Molina Healthcare by 33.4% in the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after purchasing an additional 277 shares in the last quarter. Jones Financial Companies Lllp grew its stake in Molina Healthcare by 713.3% during the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock worth $544,000 after buying an additional 1,448 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Molina Healthcare by 19.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock worth $82,172,000 after buying an additional 40,531 shares during the last quarter. Finally, Woodline Partners LP acquired a new position in Molina Healthcare during the 1st quarter valued at about $1,541,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Price Performance

Shares of NYSE:MOH opened at $233.44 on Thursday. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. The company has a market cap of $12.16 billion, a PE ratio of 69.07 and a beta of 0.74. The company’s 50 day moving average is $201.97 and its 200 day moving average is $174.74.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same period in the previous year, the business posted $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, sell-side analysts forecast that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insiders Place Their Bets

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the transaction, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Sanford C. Bernstein set a $286.00 price objective on shares of Molina Healthcare in a report on Monday. Zacks Research upgraded shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Truist Financial boosted their target price on shares of Molina Healthcare from $205.00 to $250.00 and gave the stock a “hold” rating in a research report on Tuesday. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, May 2nd. Finally, Cantor Fitzgerald lifted their price objective on shares of Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $207.06.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.